Por: MSF/donttradeourlivesaway
This week another round of negotiations on Índia-UE Free Trade Agreement took place in New Dheli. Civil society groups and international organizations are concerned that `data exclusivity` provision will menace generic drugs production and exportantion, affecting all developing countries.
Click here to read an interview wuth D.G Shah, Secretary-General of Indian Pharmaceutical Alliance (IPA), about data exclusivity and its damage to public health.
Click here to read an Medecins Sans Frontieres (MSF) release on the importance of India resistance and condening UE pressure
Click here to see MSF response for an Wall Street Journal editorial on this issue